[1]
|
NUCLEOTIDE SEQUENCE [MRNA].
DOI=10.1016/1074-7613(95)90057-8; PubMed=8777713 [NCBI, ExPASy, EBI, Israel, Japan]
Wiley S.R.,
Schooley K.,
Smolak P.J.,
Din W.S.,
Huang C.-P.,
Nicholl J.K.,
Sutherland G.R.,
Davis-Smith T.,
Rauch C.,
Smith C.A.,
Goodwin R.G.;
"Identification and characterization of a new member of the TNF family that induces apoptosis.";
Immunity 3:673-682(1995).
|
[2]
|
NUCLEOTIDE SEQUENCE [MRNA].
TISSUE=Placenta;
DOI=10.1074/jbc.271.22.12687; PubMed=8663110 [NCBI, ExPASy, EBI, Israel, Japan]
Pitti R.M.,
Marsters S.A.,
Ruppert S.,
Donahue C.J.,
Moore A.,
Ashkenazi A.;
"Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family.";
J. Biol. Chem. 271:12687-12690(1996).
|
[3]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
TISSUE=Lymph;
DOI=10.1101/gr.2596504; PubMed=15489334 [NCBI, ExPASy, EBI, Israel, Japan] The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
|
[4]
|
X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 114-281.
DOI=10.1016/S1097-2765(00)80207-5; PubMed=10549288 [NCBI, ExPASy, EBI, Israel, Japan]
Hymowitz S.G.,
Christinger H.W.,
Fuh G.,
Ultsch M.,
O'Connell M.,
Kelley R.F.,
Ashkenazi A.,
de Vos A.M.;
"Triggering cell death: the crystal structure of Apo2L/TRAIL in a complex with death receptor 5.";
Mol. Cell 4:563-571(1999).
|
[5]
|
X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 119-281.
DOI=10.1038/14935; PubMed=10542098 [NCBI, ExPASy, EBI, Israel, Japan]
Mongkolsapaya J.,
Grimes J.M.,
Chen N.,
Xu X.-N.,
Stuart D.I.,
Jones E.Y.,
Screaton G.R.;
"Structure of the TRAIL-DR5 complex reveals mechanisms conferring specificity in apoptotic initiation.";
Nat. Struct. Biol. 6:1048-1053(1999).
|
[6]
|
X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 114-281.
DOI=10.1016/S1074-7613(00)80100-4; PubMed=10485660 [NCBI, ExPASy, EBI, Israel, Japan]
Cha S.-S.,
Kim M.S.,
Choi Y.H.,
Sung B.J.,
Shin N.K.,
Shin H.C.,
Sung Y.C.,
Oh B.-H.;
"2.8 A resolution crystal structure of human TRAIL, a cytokine with selective antitumor activity.";
Immunity 11:253-261(1999).
|
|